Trial Profile

A Long-Term Extension Trial in participants with Atopic Dermatitis who participated in previous Phase 2 and 3 EDP1815 trials

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 27 Feb 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs EDP-1815 (Primary)
Indications Atopic dermatitis
Focus Adverse reactions
Sponsors Evelo Biosciences

Most Recent Events

24 Feb 2024 This Trial has been discontinued in Poland(Global end date: 26 Apr 2023) ,According to Eudra Record.
14 Jul 2023 Status changed from active, no longer recruiting to discontinued because the Parent Study (NCT05121480) did not meet the primary endpoint.
02 May 2023 Planned End Date changed from 1 Feb 2024 to 31 May 2023.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com